Vaccination Policy: It is a health policy that the government adopts for the process of vaccination. Vaccination policies have been developed over the approximately two centuries since the invention of vaccinations with the motive of suppress disease from, or boost a strong immunity system for, the population the government wants to protect. When EPI was established over 40 years ago, its main focus was on vaccinating infants with a limited number of traditional vaccines. Today the vaccine world has changed completely When EPI was established over 40 years ago, its focus was on vaccinating infants with a limited number of traditional vaccines. Today the vaccine world has changed dramatically.
Regulatory Affairs: Although the European Medicines Agency (EMA) and the World Health Organization (WHO) and the United States Food and Drug Administration (USFDA), already must established a Regulatory framework for the guideline for vaccines, the other region across the world are still at a nascent period in creating a Regulatory framework for vaccines at a national level in their own countries. As regulatory compliance for all vaccines requires some special sets of hands-on functional experience and Regulatory expertise knowledge, organizations may find it challenging to navigate through the global Regulatory framework for Vaccines.
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology Analysis of MPXV and VACV Peptides Underscores the Need to Consider Both MPXV Clades for Vaccine Development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Immunogenicity and Cryo-EM structure of native-like HIV-1 Clade-C envelope trimers derived from a pediatric elite-neutralizer
Swarandeep Singh, All India Institute of Medical Sciences, India
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Awareness and acceptability of rotavirus vaccine among mothers of under-five children in Gusau and Bungudu communities of Zamfara state, northwestern Nigeria
Attahir Abubakar, Ahmadu Bello University, Nigeria
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil